GSK-3 β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.

CONCLUSIONS: The present work identified GSK-3β as a new interacting protein for D1R functional regulation and revealed a novel mechanism for GSK-3β-regulated D1R function which may underlie D1R dysfunction in schizophrenia. PMID: 27996211 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/27996211?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - December 19, 2016 Category: Neuroscience Authors: Wang JR, Sun PH, Ren ZX, Meltzer HY, Zhen XC Tags: CNS Neurosci Ther Source Type: research

More News: Brain | Neurology | Neuroscience | Schizophrenia | Translocation